Immunovant Inc (NASDAQ:IMVT) currently has a daily average trading volume of 1.74M but it saw 1643035 shares traded in last market. With a market cap of 2.53B USD, the company’s current market price of $14.89 came rising about 5.60 while comparing to the previous closing price of $14.10. In past 52 weeks, the stock remained buoying in the range of price level as high as $34.47 and as low as $12.72.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Jefferies which initiated the stock as “Hold” in its note to investors issued on March 03, 2025, recommending a price target of $20 for it. Raymond James issued its recommendations for the stock as it resumed the price target for the stock is $36.
Over the week, IMVT’s stock price is moving 3.33% up while it is -2.17% when we observe its performance for the past one month. Year-to-date it is -39.89% down and over the past year, the stock is showing a downside performance of -48.57%.
The company is expected to be releasing its next quarterly report in June, for which analysts forecasted an EPS of -0.72 while estimate for next year EPS is -2.9.
Currently, Immunovant Inc’s total number of outstanding shares is 170.11M with 58.74% of that held by the insiders while 56.19% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -58.50% and return on equity (ROE) at -62.46%. Stock’s beta reads 0.60. Stock has a price to book (P/B) ratio of 3.58. Its return on asset (ROA) is -57.32% on average.
